Structure of 1,2,3,6,7,11beta-hexahydro-4H-pyrazino[2,1-alpha]isoquinoline-4-one CAS 61196-37-0Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

61196-37-0

Name

1,2,3,6,7,11beta-hexahydro-4H-pyrazino[2,1-alpha]isoquinoline-4-one

Syn­onyms

1,2,3,6,7,11b-Hexahydro-4H-pyrazino[2,1-a]isochinolin-4-on [Ger­man] [ACD/IUPAC Name] 1,2,3,6,7,11b-Hexahydro-4H-pyrazino[2,1-a]isoquinoléin-4-one [French] [ACD/IUPAC Name] 1,2,3,6,7,11b-Hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one [ACD/IUPAC Name] 4H-Pyrazino(2,1-a)isoquinolin-4-one, 1,2,3,6,7,11b-hexahydro-, (±)- 4H-Pyrazino[2,1-a]isoquinolin-4-one, 1,2,3,6,7,11b-hexahydro- [ACD/​Index Name] (?)-Praz­i­qua­namine 1,2,3,6,7,11B-hexahydro-4h-pyrazino(2,1-a)isoquinoline-4-one 1,2,3,6,7,11B-hexahydro-4h-pyrazino[2,1-a]isoquinoline-4-one 1,2,3,6,7,11b-hexahydropyrazino[2,1-a]isoquinolin-4-one 1,2,3,6,7,11-Hexahydro-4H-pyrazino[2,1-a]isoquinoline-4-one 1H,2H,3H,4H,6H,7H,11bH-piperazino[2,1-a]isoquinolin-4-one 2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one 55375-90-1 [RN] 61196-37-0 [RN] 61196-37-0,55375-90-1 DL-Praz­i­qua­­namine MFCD09743876 Praz­i­qua­namine rac-praz­i­qua­­namine

Mol­e­c­u­lar Structure

Structure of 1,2,3,6,7,11beta-hexahydro-4H-pyrazino[2,1-alpha]isoquinoline-4-one CAS 61196-37-0

Struc­ture of 1,2,3,6,7,11beta-hexahydro-4H-pyrazino[2,1-alpha]isoquinoline-4-one CAS 61196-37-0

SMILES

c1ccc2c(c1)CCN3C2CNCC3=O

Std­InChI

InChI=1S/C12H14N2O/c15-12-8-13-7-11-10-4-2-1-3-9(10)5-6-14(11)12/h1-4,11,13H,5-8H2

Std­InChIKey

GTR­­DOUXISKJZGL-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C12H14N2O

Mol­e­c­u­lar Weight

202.252

Prop­er­ties

Appear­ance

Yel­low or prac­ti­cal­ly white crys­talline pow­der

Melt­ing Point

116.8-118.4℃

Den­si­ty

1.24±0.1 g/​cm3 (20 ºC 760 Torr)

Safe­ty Data

WGK Germany

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our 1,2,3,6,7,11beta-hexahydro-4H-pyrazino[2,1-alpha]isoquinoline-4-one CAS 61196-37-0

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HNMR/HPLC

Puri­ty

95%min

Loss on Drying

2%max

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the phar­ma­ceu­ti­cal inter­me­di­ates of Praz­i­quan­tel

Links

This prod­uct is devel­oped by our RandD com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Ltd(http://​www​.cam​ing​.com/), and here is the cor­re­spond­ing linkhttp://​www​.cam​ing​.com/​1​2​3​6​7​1​1​b​e​t​a​-​h​e​x​a​h​y​d​r​o​-​4​h​-​p​y​r​a​z​i​n​o​2​1​-​a​l​p​h​a​i​s​o​q​u​i​n​o​l​i​n​e​-​4​-​o​n​e​-​c​a​s​-​6​1​1​9​6​-​3​7​-0/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the heart.




    andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.